ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 140 filers reported holding ENDOLOGIX INC in Q1 2016. The put-call ratio across all filers is 5.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -66.7% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $6,000 | -64.7% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $17,000 | +30.8% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $13,000 | -18.8% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $16,000 | +23.1% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $13,000 | -13.3% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $15,000 | -31.8% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | +29.4% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $17,000 | -55.3% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $38,000 | +2.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $37,000 | +48.0% | 3,000 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $25,000 | -16.7% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $30,000 | -18.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $37,000 | -19.6% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $46,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $2,142,000 | 1.45% |
| Essex Woodlands Management, Inc. | 1,257,468 | $6,684,000 | 1.39% |
| Camber Capital Management LP | 9,300,000 | $17,763,000 | 0.76% |
| PFM Health Sciences, LP | 7,408,585 | $14,150,000 | 0.21% |
| NEA Management Company, LLC | 2,490,204 | $4,756,000 | 0.20% |
| ArrowMark Colorado Holdings LLC | 10,276,145 | $19,627,000 | 0.16% |
| Brown Capital Management | 8,977,308 | $17,147,000 | 0.16% |
| Partner Investment Management, L.P. | 79,765 | $152,000 | 0.12% |
| ALTRINSIC GLOBAL ADVISORS LLC | 1,135,000 | $2,168,000 | 0.10% |
| Lombard Odier Asset Management (USA) Corp | 700,000 | $1,337,000 | 0.10% |